Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kevin Joseph Edgar is active.

Publication


Featured researches published by Kevin Joseph Edgar.


Progress in Polymer Science | 2001

Advances in cellulose ester performance and application

Kevin Joseph Edgar; Charles Michael Buchanan; John S. Debenham; Paul Andrew Rundquist; Brian Douglas Seiler; Michael Charles Shelton; Debra Tindall

Abstract In this review, we examine those areas of cellulose ester application in which there has been the greatest recent activity, and we choose to define the word ‘recent’ to include roughly the last 20xa0years. We focus on work that increases understanding of cellulose ester structure-property relationships, as well as how they relate to performance in specific applications. Our focus is on the performance of cellulose esters in modern coatings, controlled release of actives, plastics (with particular focus on biodegradable plastics), composites and laminates, optical films, and membranes and related separation media. We think that the review will prove useful to those who work with cellulose esters in these and related applications, as well as those who may wish to use this background to help them imagine new ones.


Journal of Pharmacy and Pharmacology | 2007

Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-β-cyclodextrin

Michael F. Wempe; Charles Michael Buchanan; Norma Lindsey Buchanan; Kevin Joseph Edgar; Gregory Hanley; Michael G. Ramsey; Jennifer S. Skotty; Peter J. Rice

Cyclodextrins (CDs) are one of the most successful solutions to the problem of poor drug solubility. In this study, we examined the in‐vitro effects of three CDs on the solubility of letrozole, a breast cancer drug that is practically insoluble in water. The most promising, hydroxybutenyl‐β‐cyclodextrin (HBenβCD), was used for in‐vivo studies in male and female Sprague‐Dawley rats. Letrozole is a drug with dramatic gender‐based differences in pharmacokinetics. For example, the terminal half‐life (t1/2) of letrozole following intravenous administration in male rats was 11.5 ± 1.8 h (n = 3), while in female rats it was 42.3 ± 2.9 h (n = 3). HBenβCD increased the solubility and enhanced the dissolution rate of letrozole. Complexation of letrozole with HBenβCD improved oral absorption in male rats and maximized absorption in female rats. Regardless of gender, the presence of HBenβCD in the formulation increased the in‐vivo rate of absorption. When administered in a capsule formulation with letrozole, HBenβCD resulted in a higher Cmax (61% in male rats, 42% in female), shorter Tmax values (8.4 to 6.3 h in male, 16.4 h to 5.4 h in female) and increased absolute oral bioavailability (46 ± 2 vs 38 ± 3 in male, 101 ± 3 vs 95 ± 2 in female). Thus, solubility limits both rate and extent of letrozole absorption in male rats, but limits only the rate of absorption in female rats.


Journal of Controlled Release | 2006

Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers

Eva-Maria Collnot; Christiane Baldes; Michael F. Wempe; John A. Hyatt; Lisa Navarro; Kevin Joseph Edgar; Ulrich F. Schaefer; Claus-Michael Lehr


Cellulose | 2006

Cellulose esters in drug delivery

Kevin Joseph Edgar


Archive | 1997

Process for the co-production of dissolving-grade pulp and xylan

John A. Hyatt; Richard William Fengl; Kevin Joseph Edgar; Maria Teresa Alvarez-Wright


Archive | 2003

Carbohydrate esters and polyol esters as plasticizers for polymers, compositions and articles including such plasticizers and methods of using the same

Charles Michael Buchanan; Norma Lindsey Buchanan; Kevin Joseph Edgar; Juanelle Little Lambert


Journal of Pharmaceutical Sciences | 2007

Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.

Charles Michael Buchanan; Norma Lindsey Buchanan; Kevin Joseph Edgar; Sandra Klein; James L. Little; Michael G. Ramsey; Karen M. Ruble; Vincent J. Wacher; Michael F. Wempe


Cellulose | 2006

Zero-order release formulations using a novel cellulose ester

Jessica Dee Posey-Dowty; Thelma Lee Watterson; A. Kent Wilson; Kevin Joseph Edgar; Michael Charles Shelton; Larry Ronnie Lingerfelt


Journal of Pharmaceutical Sciences | 2007

Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen–hydroxybutenyl-β-cyclodextrin formulations

Charles Michael Buchanan; Norma Lindsey Buchanan; Kevin Joseph Edgar; James L. Little; Michael Orlando Malcolm; Karen M. Ruble; Vincent J. Wacher; Michael F. Wempe


Archive | 1998

Direct process for the production of cellulose esters

Kevin Joseph Edgar; Richard Thomas Bogan

Collaboration


Dive into the Kevin Joseph Edgar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge